ÂÜÀòÂÒÂ×

Peter Kelemen has extensive work experience in the medical and pharmaceutical industry. Peter is currently working as a Senior Medical Director at CureVac since February 2022. Prior to that, they held the role of Clinical Program Leader at MorphoSys AG from March 2015 to January 2022. Peter also worked as a Global Portfolio Manager at Sandoz International from July 2012 to February 2015, and as a Medical Advisor at Novartis from January 2011 to July 2012. Peter has additional experience as a Medical Advisor and Drug Safety Product Manager at Richter Gedeon Nyrt./Magyarország from March 2007 to August 2008. Before transitioning to industry roles, Peter Kelemen worked as a Researcher or Medical Scientist at several labs from 1997 to 2007.

Peter Kelemen completed their education at Semmelweis University. Peter earned a Doctor of Medicine (MD) degree in 1997. Peter then pursued a Doctor of Philosophy (PhD) in Immunology, which they completed in 2006. Finally, they participated in the Blood Banking/Transfusion Medicine Residency Program and finished in 2007.